Nezihi Murat Karabacak, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Separation | 4 | 2020 | 1728 | 0.590 |
Why?
|
| Neoplastic Cells, Circulating | 5 | 2020 | 952 | 0.560 |
Why?
|
| Mass Spectrometry | 6 | 2019 | 2202 | 0.530 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2015 | 820 | 0.360 |
Why?
|
| Fourier Analysis | 2 | 2010 | 439 | 0.340 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 289 | 0.300 |
Why?
|
| Proteomics | 1 | 2022 | 3912 | 0.300 |
Why?
|
| Microfluidics | 3 | 2020 | 672 | 0.280 |
Why?
|
| Mutant Proteins | 1 | 2008 | 488 | 0.270 |
Why?
|
| Superoxide Dismutase | 4 | 2010 | 596 | 0.220 |
Why?
|
| Molecular Weight | 3 | 2010 | 2173 | 0.210 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 11101 | 0.160 |
Why?
|
| Muscle Neoplasms | 1 | 2019 | 130 | 0.150 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3948 | 0.140 |
Why?
|
| Stromal Cells | 2 | 2019 | 1337 | 0.140 |
Why?
|
| beta-Globins | 1 | 2017 | 111 | 0.130 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 358 | 0.130 |
Why?
|
| Blood Cells | 1 | 2017 | 309 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2019 | 1408 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 942 | 0.120 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 1563 | 0.110 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 445 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2062 | 0.100 |
Why?
|
| Insect Proteins | 1 | 2014 | 253 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2885 | 0.100 |
Why?
|
| Substance P | 2 | 2010 | 332 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 2414 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 17142 | 0.090 |
Why?
|
| Hydro-Lyases | 1 | 2011 | 93 | 0.090 |
Why?
|
| Pseudomonas putida | 1 | 2011 | 49 | 0.090 |
Why?
|
| Proteostasis Deficiencies | 1 | 2010 | 38 | 0.090 |
Why?
|
| Nitrogen Isotopes | 1 | 2010 | 83 | 0.090 |
Why?
|
| Carbon Isotopes | 1 | 2010 | 458 | 0.080 |
Why?
|
| Cattle | 3 | 2010 | 3819 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2010 | 1475 | 0.080 |
Why?
|
| Thyroglobulin | 1 | 2008 | 111 | 0.080 |
Why?
|
| Horses | 1 | 2008 | 295 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 1756 | 0.070 |
Why?
|
| Solvents | 1 | 2008 | 298 | 0.070 |
Why?
|
| Zebrafish | 1 | 2019 | 3035 | 0.070 |
Why?
|
| Databases, Protein | 1 | 2008 | 390 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5704 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1996 | 0.060 |
Why?
|
| Algorithms | 3 | 2010 | 14164 | 0.060 |
Why?
|
| Animals | 8 | 2022 | 169285 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 5442 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8648 | 0.040 |
Why?
|
| Leukapheresis | 1 | 2020 | 150 | 0.040 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2019 | 48 | 0.040 |
Why?
|
| Isotopes | 2 | 2010 | 125 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 164 | 0.040 |
Why?
|
| Neoplasms | 2 | 2017 | 22371 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11878 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 248 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 352 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 644 | 0.040 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 102 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 13422 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2017 | 200 | 0.030 |
Why?
|
| Phthalazines | 1 | 2019 | 397 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2010 | 6283 | 0.030 |
Why?
|
| Humans | 14 | 2022 | 768171 | 0.030 |
Why?
|
| Software | 1 | 2010 | 4480 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2011 | 5402 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 17623 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 347 | 0.030 |
Why?
|
| Centrifugation | 1 | 2015 | 122 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 2014 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2019 | 1344 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 874 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 1246 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 757 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2009 | 6610 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 507 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2627 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14729 | 0.030 |
Why?
|
| Male | 6 | 2022 | 364731 | 0.020 |
Why?
|
| Cell Shape | 1 | 2013 | 371 | 0.020 |
Why?
|
| Binding Sites | 2 | 2011 | 6019 | 0.020 |
Why?
|
| Transfection | 1 | 2019 | 5756 | 0.020 |
Why?
|
| Cell Size | 1 | 2013 | 626 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3612 | 0.020 |
Why?
|
| Histidine | 1 | 2011 | 301 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 749 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2059 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4280 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2010 | 301 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 768 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 355 | 0.020 |
Why?
|
| Antioxidants | 1 | 2017 | 1676 | 0.020 |
Why?
|
| Cyclotrons | 1 | 2008 | 30 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2152 | 0.020 |
Why?
|
| Mutation | 2 | 2010 | 30237 | 0.020 |
Why?
|
| Static Electricity | 1 | 2009 | 260 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 577 | 0.020 |
Why?
|
| Piperazines | 1 | 2019 | 2554 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 1216 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3348 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 1683 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4149 | 0.020 |
Why?
|
| Mice | 3 | 2019 | 82049 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5789 | 0.020 |
Why?
|
| Protein Folding | 1 | 2010 | 871 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 1951 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 1191 | 0.020 |
Why?
|
| Insulin | 2 | 2010 | 6610 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5902 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2227 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2008 | 1884 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14488 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19025 | 0.010 |
Why?
|
| Kinetics | 1 | 2011 | 6330 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10478 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2009 | 3956 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5717 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9527 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6512 | 0.010 |
Why?
|
| Female | 5 | 2019 | 397187 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 3567 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 9343 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4354 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 171502 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 223487 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 223646 | 0.000 |
Why?
|